$0.3180
At close: May 27, 5:00 PM EST
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Earnings Estimates
HEPAOTCQB
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Earnings Estimates, EPS & Revenue | OTC:HEPA
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) is scheduled to report Q2 earnings on August 13, 2026.
Over the last 4 quarters, HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. has averaged an EPS surprise of 0.39% and a revenue surprise of 0.00%.
Earnings Date
May 14
EPS
$-0.070
Quarterly Revenue
$0
Annual Revenue
–
as of Mar 31
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. Earnings History
Analyze the earnings history of HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. using advanced sorting and filters.
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) Earnings Per Share
The chart below shows HEPION PHARMS INC by Hepion Pharmaceuticals, Inc.'s reported EPS compared to analyst estimates over recent quarters.
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) Revenue
The chart below shows HEPION PHARMS INC by Hepion Pharmaceuticals, Inc.'s reported revenue compared to analyst estimates over recent quarters.
FAQ
When is HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (OTCQB:HEPA) reporting earnings?
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (OTCQB:HEPA)?
The Actual EPS was $-0.07, which missed the estimate of $0.00.
What were HEPION PHARMS INC by Hepion Pharmaceuticals, Inc.’s (OTCQB:HEPA) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
